Vanguard Group Inc Nektar Therapeutics Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

A detailed history of Vanguard Group Inc transactions in Nektar Therapeutics stock. As of the latest transaction made, Vanguard Group Inc holds 13,120,793 shares of NKTR stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,120,793
Previous 12,967,498 1.18%
Holding current value
$14 Million
Previous $16.1 Million 6.08%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1.11 - $1.48 $170,157 - $226,876
153,295 Added 1.18%
13,120,793 $17.1 Million
Q2 2024

Aug 13, 2024
BUY
$0.9 - $1.83 $826,524 - $1.68 Million
918,360 Added 7.62%
12,967,498 $16.1 Million
Q1 2024

May 10, 2024
BUY
$0.49 - $0.96 $3,069 - $6,014
6,265 Added 0.05%
12,049,138 $11.2 Million
Q4 2023

Feb 14, 2024
SELL
$0.42 - $0.57 $7,675 - $10,416
-18,274 Reduced 0.15%
12,042,873 $6.74 Million
Q3 2023

Nov 14, 2023
BUY
$0.51 - $1.05 $2,529 - $5,208
4,960 Added 0.04%
12,061,147 $7.24 Million
Q2 2023

Aug 14, 2023
SELL
$0.53 - $1.03 $4.06 Million - $7.88 Million
-7,652,250 Reduced 38.83%
12,056,187 $6.99 Million
Q1 2023

May 15, 2023
SELL
$0.64 - $3.15 $2.15 Million - $10.6 Million
-3,357,338 Reduced 14.56%
19,708,437 $13.8 Million
Q4 2022

Feb 10, 2023
SELL
$2.03 - $4.28 $201,313 - $424,443
-99,169 Reduced 0.43%
23,065,775 $52.1 Million
Q3 2022

Nov 14, 2022
BUY
$3.04 - $5.14 $7.78 Million - $13.2 Million
2,559,732 Added 12.42%
23,164,944 $74.1 Million
Q2 2022

Aug 12, 2022
BUY
$3.17 - $6.17 $3.72 Million - $7.25 Million
1,174,827 Added 6.05%
20,605,212 $78.3 Million
Q1 2022

May 13, 2022
BUY
$4.16 - $13.72 $3.82 Million - $12.6 Million
918,474 Added 4.96%
19,430,385 $105 Million
Q4 2021

Feb 14, 2022
BUY
$10.83 - $18.41 $15.2 Million - $25.8 Million
1,403,646 Added 8.2%
18,511,911 $250 Million
Q3 2021

Nov 12, 2021
BUY
$13.07 - $18.84 $1.34 Million - $1.94 Million
102,719 Added 0.6%
17,108,265 $307 Million
Q2 2021

Aug 13, 2021
BUY
$16.52 - $20.4 $281 Million - $347 Million
17,005,546 New
17,005,546 $292 Million

Others Institutions Holding NKTR

# of Institutions
147
Shares Held
139M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $201M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email